Condition: Nocebo Effect · Pain Anticipation · Sponsor: Universite de Picardie Jules Verne
The purpose of this study is to determine whether the anticipation of pain influences gait control and psychophysiological responses in healthy individuals. Participants will receive a neutral cream described either as potentially painful (experimental group) or inert (control group), and their behavioral and physiological adaptations will be measured during walking tasks.
This description comes directly from the study's public registry record.
Jennifer Burgos-Tirado, Master · 07 71 27 11 35 · jennifer.burgos.tirado@u-picardie.fr
Always discuss trial participation with your own doctor first.
| Université de Picardie Jules Verne | Amiens, France | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT06929559